Burst Diagnostics

$2.4Mlatest round · Venture round · Jan 2024 · 2 yr ago
$581kgrants · 2 grants · CORDIS
50+team · employees, estimated range
2022founded

Overview

Rapid, quantitative, lab-quality diagnostics when and where you need them. Custom assays and clinical tests built for the point of need.

Funding and backers

Total raised
$2.4M
3 rounds on record
Latest round
$2.4M
Venture round · Jan 2024 · 2 yr ago
Team
51-200
employees, estimated range
Grants
$581k
2 grants · CORDIS
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 15, 2025 Won a grant $301k · CORDIS Jan 3, 2024 Raised a round Venture round $2.4M · SEC Form D Aug 1, 2023 Won a grant $280k · CORDIS 2022 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Sep 2025 $301k — CORDIS
Venture round Jan 2024 $2.4M — SEC Form D
Grant Aug 2023 $280k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity Burst Diagnostics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Charles HenryExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Techstars
backs Labby Inc.
High-Tech Gründerfonds
backs Signatope
E14 Fund
backs Labby Inc.
Imperial College London
backs DNAe
Blue Lion
backs Hemetron Logo
arise – Der Deep-Tech Accelerator
backs Solios Diagnostics
Similar startupsby what they do, their industry and backers
LC Acquisition, LLC1-10 employees · 2 roles
Get trusted, lab-quality results anywhere with the Focus LC®—a compact, easy-to-integrate HPLC system designed for flexibility and…
Labby Inc.51-200 employees
Lab-quality milk analysis in under 10 seconds, cow-side. Every milking, no samples. Real-time intelligence for the dairy supply chain.
Novel MicrodevicesConvertible Note $1M · 7 mo ago · Founded 2021 · 11-50 employees · 1 role
Problem Solution Validation Tests & Pipeline About Us In the News White Papers Careers Contact My Novel Dx Novel Dx PCR Platform…
Solios DiagnosticsFounded 2022 · 51-200 employees
Diagnostic simplicity in every moment. For everyone. Solios offers integrated platforms for point of care rapid diagnostic tests…
DNAeVenture round · 5 yr ago
DNAe. The first true point-of-need Next-Generation Sequencing company.
Signatope
Immunoassays for any Protein, any Specimen and any Species. SIGNATOPE offers next generation quantitative assays for your protein biomarker…

Financials

Total raised
$3M
Latest round
Grant
Funding rounds
3
Funding rounds
Round Announced Amount
Grant 2025 $301k Details
Venture - Series Unknown 2024 $2.4M Details
Grant 2023 $280k Details

People

Charles Henry
Executive Officer, Director
SEC Form D
Tim Jones
Director
SEC Form D
Xi Yu Larry Jia
Director
SEC Form D
Mary Gunn
Director
SEC Form D
Cathy Petti
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Fort Collins United States
HQ
Reach out to learn more about our technology, team, or custom assay development capabilities.
50-200 est. staff
320 East Vine Drive, Fort Collins, Colorado 80524
company site